C50.9
Conditions
Interventions
Group 1: All patients included in the study will receive a one-time questionnaire, which will be filled out in the presence of a person appointed by the study director. Data acquisition is expected to
Sponsors
Universitätsfrauenklinik Ulm
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All patients with metastatic breast cancer who are affiliated to the Ulm University Women's Clinic are to be included.
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoints of this study will be: • the symptom burden prior to the diagnosis of metastatic breast cancer • the latency between the appearance of initial disease-related symptoms and the diagnosis of metastatic breast cancer • the professional groups involved in the diagnosis process • the correlation between the computer tomographic tumor burden and the symptom burden The above-mentioned questions will be determined retrospectively through patient questionnaires and data from the patient file. | — |
Secondary
| Measure | Time frame |
|---|---|
| • patient adherence to pre- or post-treatment as well as patient participation • initiated examinations | — |
Countries
Germany
Contacts
Public ContactHenning Schäffler
Universitätsfrauenklinik Ulm
Outcome results
None listed